Parolaro D, Massi P, Izzo AA, et al. Phytocannabinoids in the treatment of cancer. US20180042975, 2018.
Roura XN. Phytocannabinoids in the treatment of cancer. US20180042975, 2017.
Shetty MV. Herbal composition for the treatment and management of cancer and method of preparation thereof. US10478465, 2019.
Soman GS. Process for the preparation of the CO2 extract of Azadirachta indica and herbal compositions thereof for the treatment of cancers. US20200069636, 2020.
Mei BC, Lyga JW. Vernonia cinerea extracts and methods of use. US20150359732, 2015.
Segond C, Loiseau A, Petit V, Theron E. Use of vernonia extract. US9339521, 2016.
Segond C, Loiseau A, Petit V, Theron E. Use of veronia extract. US20170007654, 2017.
Chang LC, Turkson J, Wongwiwatthananukit S, Youn UJ, Sun D. Novel sesquiterpenoid stat3 inhibitors. US20160137663, 2016.
Maliyakkal N, Udupa N, Pai KSR, Rangarajan A. Cytotoxic and apoptotic activities of extracts of Withania somnifera and Tinospora cordifolia in human breast cancer cells. Int J Appl Res Nat Prod 2013; 6(4): 1-10.
Zhang Z, Wang X, Huang S, et al. Apoptosis inhibitors. US20190152960, 2019.
Janne PA, Engelman J, Cantley LC. Methods for treating cancer resistant to ERBB therapeutics. US10322097, 2017.
Wong KW, Law YK, Efferth T, Su-Wei XU, Hamdoun S, Liu L. Treatment of subjects with multidrug-resistant cancer. US10322097, 2019.
Wong KW, Law YK, Efferth T, Kadioglu O, Liu L. Prenylated isoflavones for treatment of subjects with multidrug-resistant cancer. US9974766, 2018.
Laskin JD, Udasin R, Aleksunes L. Methods and compositions for modulating transport of a drug. US10376556, 2019.
Hongying Z. ABCG2 monoclonal antibody and uses thereof. US20190248912, 2020.
Chang C-H, Goldenberg DM. A combination of ABCG2 inhibitors with sacituzumab govitecan (immu-132) overcomes resistance to SN-38 in TROP-2 expressing cancers US20170224837A1, 2017.
Whittle B, Guy G, Downs D, Pate DW. Processes and apparatus for the extraction of active substances and enriched extracts from natural products. US9034395, 2015.
Stitzlein K. Quantitative HPTLC cannabinoid field testing device and method. US20200018734, 2019.
Schicht O. Gel electrophoresis system for single-cell gel electrophoresis. US20180095055, 2020.
Szabodora K, Turkagnes T, Kucsmatamas H, Szakacslaszlo Homolyabalazs SV. Fluorescent dye accumulation assay. WO2019081957, 2017.
Perillo DA, Buonocore G, Balduini W. A pharmaceutical composition for the parenteral administration of melatonin, and a process for its preparation. WO2020058817, 2018.
Subramoni P, Chandrasekharan S, Madhavan J, et al. Herbal composition. US20200085904, 2020.
Shaikh AM, Shrivastava B, Apte KG, Navale SD. Medicinal plants as a potential source of anticancer agents: A review. J Pharmacogn Phytochem 2016; 5(2): 291.
Simsek SA, Simsek S. A pharmaceutical composition with enhanced bioavailability containing a medical herbal extract. EP3581172, 2019.
Hajjar DA, Kremb S, Voolstra C, Ravasi T. Extracts of Saudi Arabian herbal plants, an anti-cancer method using such extracts, and cytological profiling using an automated high-content imaging technique. US20190298786, 2019.
Davey NS, Rustgi N, Priya P, Davey SR, Rustgi V. Herbal drug composition containing probiotic and optionally prebiotic and/or active pharmaceutical ingredient. US20170368135, 2017.
Soman G, Wargovich M. Compositions of Azadirachta indica and methods of treating cancer. WO2020047405A1, 2019.
Kogon BD. Phytochemical extraction systems, methods, and devices. US20190282924, 2019.
Hergenrother PJ, Putt KS, Peterson QP, Valerie F. Compounds and methods for the treatment of cancer. US20190201394, 2019.
Zhimei DU. Methods of using cell-cycle inhibitors to modulate one or more properties of cell culture. US20180087079, 2018.
Maizels N, Le Q. Restricting nuclear protein to specific phases of the cell cycle. US20160369258, 2016.
Chen-Kiang S, Di Liberto M, Huang X. Targeting CDK4 and CDK6 in cancer therapy. US9259399, 2016.
Bernini F, Adorni MP, Petronini PG, et al. New MDR1 inhibitors for overcoming multidrug resistance. US20170224647, 2017.
Wise JG, Vogel PD, Brewer FK, Follit CA. Inhibitors of multidrug resistance transporter P-glycoprotein. US20200138816, 2019.
Chen ZS, Shi Z, Ashby CR Jr. Use of phosphodiesterase inhibitors for treating multidrug resistance. US8673914, 2014.
Henrich CJ, Bokesch HR, Bates SE, et al. Method of inhibiting ABCG2 and related treatments. US9937217, 2018.
Breedveld P. Method for identifying modulators of BCRP/ABCG2-mediated ATP release and use of said modulators for treating diseases. EP2829880, 2015.